EXPLANATORY NOTE

Unless otherwise indicated or the context otherwise requires, all references in this Quarterly Report on Form 10-Q (this “Report”) to “we,” “us,” “our,” “Jones,” “Jones Soda,” and the “Company” are to Jones Soda Co., a Washington corporation, and our wholly-owned subsidiaries.

In addition, unless otherwise indicated or the context otherwise requires, all references in this Report to “Jones Soda” refer to our premium beverages, including Jones® Soda and Lemoncocco® sold under the trademarked brand name “Jones Soda Co.®”

CAUTIONARY NOTICE REGARDING FORWARD LOOKING STATEMENTS

We desire to take advantage of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. This Report contains a number of forward-looking statements that reflect management’s current views and expectations with respect to our business, strategies, products, future results and events, and financial performance. All statements made in this Report other than statements of historical fact, including statements that address operating performance, the economy, events or developments that management expects or anticipates will or may occur in the future, including statements related to case sales, revenues, profitability, distributor channels, new products or markets, adequacy of funds from operations, cash flows and financing, potential strategic transactions, statements regarding future operating results and non-historical information, are forward-looking statements. In particular, the words such as “believe,” “expect,” “intend,” “anticipate,” “estimate,” “may,” “will,” “can,” “plan,” “predict,” “could,” “future,” “continue,” variations of such words, and similar expressions identify forward-looking statements, but are not the exclusive means of identifying such statements and their absence does not mean that the statement is not forward-looking.

Readers should not place undue reliance on these forward-looking statements, which are based on management’s current expectations and projections about future events, are not guarantees of future performance, are subject to risks, uncertainties and assumptions and apply only as of the date of this Report. Our actual results, performance or achievements could differ materially from historical results as well as from the results expressed in, anticipated or implied by these forward-looking statements. Except as required by law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

In particular, our business, including our financial condition and results of operations may be impacted by a number of factors, including, but not limited to, the following:

For a discussion of some of the factors that may affect our business, results and prospects, see “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 20212022 filed with the Securities and Exchange Commission (“SEC”) on March 14, 202229, 2023 and in our other reports we file with the SEC, including our periodic reports on Form 10-Q and current reports on Form 8-K. Readers are also urged to carefully review and consider the various disclosures made by us in this Report and in our other reports we file with the SEC, including our periodic reports on Forms 10-Q and current reports on Form 8-K, and those described from time to time in our press releases and other communications, which attempt to advise interested parties of the risks and factors that may affect our business, prospects and results of operations.

PART 1 – FINANCIAL INFORMATION

JONES SODA CO.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

See accompanying notes to condensed consolidated financial statements.

JONES SODA CO.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

See accompanying notes to condensed consolidated financial statements.

JONES SODA CO.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Unaudited)

See accompanying notes to condensed consolidated financial statements.

JONES SODA CO.

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(Unaudited)

See accompanying notes to condensed consolidated financial statements.

JONES SODA CO.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

See accompanying notes to condensed consolidated financial statements.

JONES SODA CO.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Jones Soda Co. develops, produces, markets and distributes premium beverages which it sells and distributes primarily in the United States and Canada through its network of independent distributors and directly to its national and regional retail accounts.

In addition, following the closing of the Plan of Arrangement (See note 4(d)), we intend to use the proceeds from our recent financings exclusively for the purpose of expandinghave expanded our business to the production of cannabis-containing beverages and related products.

We are a Washington corporation and have four operatingsix subsidiaries, Jones Soda Co. (USA) Inc., Jones Soda (Canada) Inc., Pinestar GoldJones Soda Cannabis Inc., and Mary Jones Holdings Inc., and Mary Jones California, LLC, Mary Jones Michigan, LLC, and Pinestar Gold Inc. (Subsidiaries).

Basis of presentation, consolidation and use of estimates

The accompanying condensed consolidated balance sheet as of December 31, 2021,2022, which has been derived from our audited consolidated financial statements, and unaudited interim condensed consolidated financial statements as of September 30, 2022,March 31, 2023, have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the Securities and Exchange Commission (“SEC”) rules and regulations applicable to interim financial reporting. The condensed consolidated financial statements include our accounts and the accounts of our subsidiaries. All intercompany transactions between us and our subsidiaries have been eliminated in consolidation.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all material adjustments, consisting only of those of a normal and recurring nature, considered necessary for a fair presentation of our financial position, results of operations and cash flows at the dates and for the periods presented.  Preparing financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. Significant items subject to such estimates and assumptions include, but are not limited to, inventory valuation, depreciable lives and valuation of capital assets, valuation allowances for receivables, trade promotion liabilities, stock-based compensation expense, valuation allowance for deferred income tax assets, contingencies, and forecasts supporting the going concern assumption and related disclosures. Actual results could differ from those estimates. The operating results for the interim periods presented are not necessarily indicative of the results expected for the full year. These financial statements should be read in conjunction with the audited financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.2022.

Liquidity

As of September 30, 2022March 31, 2023 and December 31 2021,2022, we had cash and cash-equivalents of approximately $8.2$6.4 million and $4.7$8.0 million, respectively, and working capital of approximately $12.9$10.5 million and $6.0$11.6 million, respectively. Net cash used in operations during the ninethree months ended September 30, 2022March 31, 2023 and 20212022 totaled approximately $5.9$1.3 million and $702,000,$2.0 million, respectively. Net cash used in operations increaseddecreased primarily due to the increasedecrease in start-up expenses related to expanding our business to the productionlaunch of the cannabis-containing beverages and related products for the ninethree months ended September 30, 2022.March 31, 2023.

During theWe did ninenot months ended September 30, 2022, we issued $3,000,000 in Contingent Convertible Debentures (See note 4), that fully converted into 6,022,192 shares of common stock on May 16, 2022.

Additionally, upon the consummation of a statutory plan of arrangement under the Business Corporations Act (British Columbia) (the “Plan of Arrangement”) with Pinestar Gold Inc. (“Pinestar”) the Company received $7.1 million in net proceeds from a subscription receipt offering completed by Pinestar (the “Pinestar Subscription Receipt Offering”) prior to the Plan of Arrangement. The Plan of Arrangement resulted in issuance of an aggregate of 20,000,048 shares of the Company’s common stock (the “Jones Shares”) which were issued in exchange for all ofthe outstanding common shares of Pinestar (the “Pinestar Shares”), including the Pinestar Shares issued in connection with the Pinestar Subscription Receipt Offering, on a one-for-one basis.

During the three and nine months ended September 30, 2022, we received $0receive any cash from the cash exercise of stock options. During theoptions as of threeMarch 31, 2023 andor nine2022. months ended September 30, 2021, we received $228,000 and $295,000, respectively, from the cash exercise of stock options. From time to time, we may receive additional cash through the exercise of stock options or stock warrants. However, we cannot predict the timing or amount of cash proceeds we may receive from the exercise, if at all, of any of the outstanding stock options or warrants.

We intend to continually monitor and adjust our operating plan as necessary to respond to developments in our business, our markets and the broader economy. In addition, the continuation of the COVID-19 pandemic and uncertain supply chain conditions, may reduce demand for certain products, and may negatively impact our business.

As of the date of this Report, as a result of our cash on hand, we believe that our current cash and cash equivalents will be sufficient to meet the Company’s funding requirements for one year after these condensed consolidated financial statements are issued.

Seasonality and other fluctuations

Our sales are seasonal and we experience fluctuations in quarterly results as a result of many factors. We historically have generated a greater percentage of our revenues during the warm weather months of April through September. Sales may fluctuate materially on a quarter to quarter basis or an annual basis when we launch a new product or fill the “pipeline” of a new distribution partner or a large retail partner. Sales results may also fluctuate based on the number of stock keeping units (“SKU”) selected or removed by our distributors and retail partners through the normal course of serving consumers in the dynamic, trend-oriented beverage industry. As a result, management believes that period-to-period comparisons of results of operations are not necessarily meaningful and should not be relied upon as any indication of future performance or results expected for the fiscal year.

Revenue recognition

Our contracts have a single performance obligation which is satisfied at the point in time when the customer has title and the significant risks and rewards of ownership of the product. Title and the significant risk and rewards of ownership are deemed to transfer when products are loaded onto a truck for shipment or Free on Board (“FOB”) shipping point. We primarily receive fixed consideration for sales of product, subject to adjustment as described below. Shipping and handling amounts paid by customers are primarily for online orders, and are included in revenue, and totaled $34,000 and $36,000$41,000 for the three months ended September 30, 2022March 31, 2023. and 2021, respectively, and $120,000 and $91,000 for the nine months ended September 30, 2022 and 2021, respectively. Sales tax and other similar taxes are excluded from revenue.

See Note 1, on our most recently filed Form 10-K filed on March 14, 202229, 2023 for our revenue recognition policy. 

Revenue is recorded net of provisions for discounts, slotting fees payable by us to retailers to stock our products and promotion allowances. Discounts, slotting fees and promotional allowances vary the consideration we are entitled to in exchange for the sale of products to distributors. We estimate these discounts, slotting fees and promotional allowances in the same period that the revenue is recognized for product sales to customers. These estimates are based on contract terms and our historical experience with similar programs and require management judgement with respect to estimating customer participation and performance levels. Differences between estimated expense and actual costs are normally insignificant and are recognized in earnings in the period such differences are determined. The amount of revenue recognized represents the amount that will not be subject to a significant future reversal of revenue. The liability for promotional allowances is included in accrued expenses on the consolidated balance sheets. Amounts paid for slotting fees are recorded as prepaid expenses on the consolidated balance sheets and amortized over the corresponding term. For the quarters ended September 30, 2022March 31, 2023 and 2021,2022, our revenue was reduced by $397,000$305,000 and $377,000,$308,000, respectively and for the nine months ended September 30, 2022 and 2021, our revenue was reduced by $1.2 million in each year respectively, in each case for slotting fees and promotion allowances.

All sales to distributors and customers are generally final. In limited instances we may accept returned product due to quality issues or distributor terminations, and in such situations we would have variable consideration. To date, returns have not been material. Our customers generally pay within 30 days from the receipt of a valid invoice. We offer prompt pay discounts of up to 2% to certain customers typically for payments made within 15 days. Prompt pay discounts are estimated in the period of sale based on experience with sales to eligible customers. Early pay discounts are recorded as a deduction to the accounts receivable balance presented on the condensed consolidated balance sheets.

The accounts receivable balance primarily includes balances from trades sales to distributors and retail customers. The allowance for doubtful accounts is the best estimate of the amount of probable credit losses in existing accounts receivable. We determine the allowance for doubtful accounts based primarily on historical write-off experience. Account balances that are deemed uncollectible are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Allowances for doubtful accounts of $108,000$115,000 and $114,000$110,000 as of September 30, 2022March 31, 2023 and December 31, 2021,2022, respectively, were netted against accounts receivable. No impairment losses were recognized for the ninethree months ended September 30, 2022March 31, 2023 and for the year ended December 31, 2021.2022. Changes in accounts receivable are primarily due to the timing and magnitude of orders for products, the timing of when control of products is transferred to distributors and the timing of cash collections.

As of September 30, 2022,March 31, 2023, twoone of our independent customers made up 27%11% of our outstanding accounts receivable. As of December 31, 2021,2022, one of our independenttwo customers made up 19%22% of our outstanding accounts receivable.

Net loss per share

Basic net loss per share is computed using the weighted average number of common shares outstanding during the periods. Diluted earnings per share is computed by adjusting the weighted average number of common shares by the effective net exercise or conversion of all dilutive securities. Due to the net loss induring the three and ninemonths ended September 30, March 31, 2023 and 2022,outstanding stock options amounting to 3,236,832 were anti-dilutive. Due to the net loss in the three6,767,290 and nine months ended September 30, 2021, 3,957,085 shares, outstanding stock options amounting to 3,199,573 shares,warrants of  27,721,945 and 0, shares issuable upon the conversion of the Convertible Notes (as defined in note 43) of 416,341,0 and 38,662, and shares issuable upon the conversion of the Convertible Debenture (as defined in note 43) of 0 and 4,000,000, at March 31, 2023 and 2022, respectively, were anti-dilutive.

Recent accounting pronouncements

In August 2020,No new accounting pronouncements issued or effective during 2022 had, or are expected to have, a material impact on the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, “Debt-Debt with Conversion and other options” (“ASU 2020-06”), which simplifies the accounting for convertible debt instruments and convertible preferred stock. This ASU is effective for public companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted. We are evaluating the impact ASU 2020-06 could have on ourCompany’s consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments: Credit Losses (“ASU 2016-13”), which changes the impairment model for most financial instruments, including trade receivables from an incurred loss method to a new forward-looking approach, based on expected losses. The estimate of expected credit losses will require entities to incorporate considerations of historical information, current information and reasonable and supportable forecasts. This ASU is effective for us in the first quarter of 2023 and must be adopted using a modified retrospective transition approach. We are currently evaluating the potential impact that the adoption of ASU 2016-13 will have on our consolidated financial statements.

Inventory consisted of the following (in thousands):

Finished goods primarily include product ready for shipment, as well as promotional merchandise held for sale. Raw materials primarily include ingredients, concentrate and packaging. For the three months ended September 30, 2022March 31, 2023 and 2021,2022, we recorded obsolete inventory expenses of $16,000$6,000 and $9,000,$12,000, respectively. For the nine months ended September 30, 2022 and 2021, we recorded obsolete inventory expenses of $37,000 and $25,000, respectively.

During the three months ended September 30, 2022 we terminated our lease of approximately 6,500 square feet of retail/office space in Seattle, Washington for our principal executive and administrative offices. The initial term of the lease was five years; in February 2020, we amended the lease to extend the term through February 28, 2025. As a result of the lease amendment, we recognized a lease liability and right-of-use asset of $556,000 which represents the remaining lease payments discounted at a rate of 4%. Due to the termination, we removed the right-of-use asset and total lease liabilities of $310,000 and $322,000, respectively from our balance sheet. The remaining difference of $12,000 was recorded as Other Income. Additionally, we did incur a net termination fee of $41,000 upon execution of the termination agreement.

On September 1, 2022 we entered into a membership/licensing agreement with Saltbox Inc. This agreement gives us right to our portion of a shared office (“Suite”) and warehouse facility in Seattle, WA. The structure of the agreement is a revocable license to access the suite and warehouse. The relationship between Saltbox Inc. and Jones Soda is that of a licensor and licensee only, and not a landlord-tenant or lessor-lessee relationship. The agreement does not give right, title, interest, easement, or lien in or to Saltbox Inc’s business, the Suite, the Premises, or anything contained therein, nor will the Agreement be interpreted or construed as a lease. Thus, we will not be recording a lease liability or right-of-use asset associated with this agreement. The term of the agreement is for 1 year with an option to renew and 12 monthly payments of $6,000 payable each month.

During the quarters ended September 30, 2022 and 2021, we incurred rental expenses on the previous lease of $21,000 and $42,000, respectively and during the nine months ended September 30, 2022 and 2021, we incurred rental expenses on the previous lease of $109,000 and $122,000, respectively. During the quarter ended September 30, 2022, we incurred licensing expenses for right to our suite and warehouse of $6,000.

2018 Convertible Subordinated Note Payable

On March 23, 2018, and April 18, 2018, we issued and sold an aggregate principal amount of $2,920,000 of convertible subordinated promissory notes (the “2018 Convertible Notes”) to institutional investors and our management team, and other individual investors.

The 2018 Convertible Notes had a four-year term from the date of issuance and bear interest at 6% per annum until maturity on March 23, 2022, and April 18, 2022. The holders could convert the 2018 Convertible Notes at any time into the number of shares of our common stock equal to the quotient obtained by dividing (i) the amount of the unpaid principal and interest on such 2018 Convertible Note by (ii) $0.32 (the “Conversion Price”). The Conversion Price was subject to anti-dilution adjustment on a broad-based, weighted average basis if we issue shares or equity-linked instruments at a conversion price below $0.32 per share. No payments of principal or interest arewere due until the maturity.

The 2018 Convertible Notes were subordinated in right of payment to the prior payment in full of all of our Senior Indebtedness, which is defined as amounts due in connection with our indebtedness for borrowed money to banks, commercial finance lenders, or other lending institutions regularly engaged in the business of lending money, with certain restrictions.

The fair value of our common stock on the March 23, 2018, closing date for the issuance of the first tranche of the 2018 Convertible Notes was $0.36 per share, therefore, the 2018 Convertible Notes contained a beneficial conversion feature with an aggregate intrinsic value of $350,000. The fair value of our common stock on the April 18, 2018, closing date for the issuance of the second tranche of the 2018 Convertible Notes was $0.30 per share, which did not result in an additional beneficial conversion feature. The resulting debt discount for the 2018 Convertible Notes issued on March 23, 2018 is presented as a direct deduction from the carrying value of the 2018 Convertible Notes and was recorded with an increase to additional paid-in capital. The discount along with the related closing costs amounting to $137,000 were amortized through interest expense over the term of the 2018 Convertible Notes. As of April 18, 2022 all convertible notes havehad been converted into shares and the current balance of the 2018 Convertible Subordinated Note Payable as of September 30, 2022March 31, 2023 is $0.

2021 Unsecured Convertible Debenture

On July 14, 2021, we issued a $2,000,000 5.00% unsecured convertible debenture due July 14, 2023 (the “2021 Debenture”) to SOL Verano Blocker 1 LLC that was convertible into units of the Company (each a “Jones Unit”) at a conversion price of $0.50 per Jones Unit, with each Jones Unit consisting of one Jones Shareshare of our common stock and one share purchase special warrant of Jones (each a “Jones Special Warrant”). Each Jones Special Warrant will be exercisable into one Jones Shareshare of our common stock at a price of $0.625 per Jones Shareshare for a period of 24 months from the date of issuance, conditional upon us increasing our authorized capital to an amount to cover the Jones Sharesour shares of common stock issuable pursuant to all of the outstanding Jones Special Warrants as well as the other Jones Sharesshares of our common stock issuable pursuant to our then-outstanding convertible/exercisable securities. The 2021 Debenture accrued interest at a rate of 5.00% and we had $47,000 of interest due to SOL Verano Blocker 1 LLC on December 31, 2021.

The closing of the Plan of Arrangement the statutory plan of arrangement under the Business Corporations Act (British Columbia) (the “Plan of Arrangement”) with Pinestar Gold Inc. (“Pinestar”) in February 2022 resulted in the automatic conversion of the 2021 Debenture into an aggregate of 4,025,035 Jones Sharesshares of our common stock and 4,025,035 Jones Special Warrants at a conversion price of $0.50 per Jones Shareshare of common stock and Jones Special Warrant. As a result, the carrying amount of the converted principal amount of such 2021 Unsecured Convertible Debenture, in an aggregate amount of $2,000,000, was credited to common stock.

2022 Unsecured Convertible Debenture

On February 9, 2022, we issued $3,000,000 in aggregate principal amount of 3.00% unsecured convertible debentures due February 9, 2023 (the “Contingent Convertible Debentures”), which were converted into Jones Units of Jones at a conversion price of $0.50$0.50 per Jones Unit on May 16, 2022. The Contingent Convertible Debentures were automatically convertible into Jones Units upon Jones Soda increasing its authorized capital to an amount to cover the Jones Sharesour shares of common stock issuable pursuant to all of the outstanding Contingent Convertible Debentures as well as all of the other then outstanding convertible/exercisable securities of Jones (a “Conversion Event”). The Contingent Convertible Debentures were only convertible into Jones Units upon the occurrence of a Conversion Event. The Contingent Convertible Debentures were set to mature on February 9, 2023 (the “Convertible Debenture Maturity Date”) and began accruing interest at a rate of 3.00% commencing on April 1, 2022. Under the terms of the Contingent Convertible Debentures, the Company covenantscovenanted to the holders of the Contingent Convertible Debentures that the Company will use their commercially reasonable efforts to cause the Conversion Event to occur as soon as practicable after the closing of the Plan of Arrangement . We received net proceeds of $538,000 prior to December 31, 2021 and the remaining of the total $3,000,000 during the quarter ended March 31, 2022. The related closing costs amounting to $108,000 were amortized through interest expense over the term of the Contingent Convertible Debentures. On May 16, 2022 all Contingent Convertible Debentures were converted into common stock,Jones Units, and the remaining unamortized capitalized closing costs were expensed, and the current balance of the Contingent Convertible Debentures as of September 30, 2022March 31, 2023 was $0.

On May 16, 2022, our shareholders approved the adoption of the Jones Soda Co. 2022 Omnibus Equity Incentive Plan (the "2022 Plan"), which replaced the 2011 Plan (defined below) and provides for the granting incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units and other stock-based awards to participants to acquire shares of Company common stock under the 2022 Plan. Under the terms of the 2022 Plan, the sum of (i) 10,000,000 shares of the Company’s common stock, plus (ii) the number of shares of common stock reserved, but unissued under the 2011 Plan, plus (iii) the number of shares of common stock underlying forfeited awards under the 2011 Plan are initially available for issuance as awards under the 2022 Plan.

1,936,074 shares of common stock reserved under the terms of our 2011 Incentive Plan (the “2011 Plan”) but unissued were transferred to the reserve for the 2022 Plan. Thus, the total number of shares of common stock authorized under the 2022Plan was 11,936,074 shares.

Under the terms of the 2022 Plan, the Board may grant awards to employees, officers, directors, consultants, agents, advisors and independent contractors. Stock options are granted with an exercise price equal to the closing price of our stock on the date of grant, and generally have a ten-year term. As of September 30, 2022,March 31, 2023, there were 7,746,0746,284,574 shares of unissued common stock authorized and available for future awards under the Plan.

A summary of our stock option activity is as follows:

Beginning on May 13, 2022 the Company’s board of directors (the “Board”) determined that it was in the best interests of the Company to periodically award restricted stock units as equity compensation for non-employee directors atupon the discretionrecommendation of the Compensation and Governance Committee of the Board in lieu of stock options. Each restricted stock unit granted vests incrementally over the period in the specific award agreement, and certain restricted stock awards will immediately vest upon the occurrence of a "Change in Control" as defined in the 2022 Plan. For

On December 30, 2022, the period fromCompany entered into rescission agreements (the “Rescission Agreements”) with the certain non-employee directors on the Board who were awarded restricted stock units during January 1, 2020 2022through as well as the Company’s Chief Executive Officer and President who received restricted stock units during 2022 under the terms of his employment agreement with the Company. Under the terms of the Rescission Agreements, each of the Company and the applicable restricted stock unit grantee agreed to rescind and cancel for no consideration all currently outstanding restricted stock units previously granted to each such grantee during 2022 as well as all shares of the Company’s common stock previously issued to any such grantee as a result of the vesting of any restricted stock units in August 2022.

In February 15, 2022,2023, the Board determined that it was in the best interests of the Company to periodically award stock options as equity compensation for non-employee director service consisteddirectors upon the recommendation of the grant of an annual non-qualified stock option award that vested on the first anniversaryCompensation and Governance Committee of the date of grant (subject to the director’s continuing service as of such anniversary date), with the number of shares underlying such award being determined by dividing $25,000 by the closing share price (as quoted on the OTCQB marketplace) on the date of grant (which was the first trading dayBoard in January in each calendar year), and such stock option award had an exercise price equal to our closing share price (as quoted on the OTCQB marketplace) on the date of grant. Prior to February 15, 2022, when joining the Board, each non-employee director was previously granted a non-qualified stock option award that vested on the first anniversary of the date of grant (subject to the director’s continuing service as of such anniversary date), with the number of shares underlying such award being determined by dividing $25,000 by our closing stock price on the first trading day following the date on which such director is appointed), prorated based on the date on which such director is appointed, and which stock option shall be granted as of the first trading day following the date on which such director was appointed, and had an exercise price equal to our closing share price (as quoted on the OTCQB marketplace) on the date of grant. The stock option and restricted stock unit awards described above are governed by either the 2022 Plan or the 2011 Plan (if granted prior to the adoption of the 2022 Plan) and standard form of stock option grant notice and agreement and standard formlieu of restricted stock unit grant notice andunits. Each stock option granted vests incrementally over the period in the specific award agreement.

There was no restricted stock activity during the three months ended March 31, 2022. A summary of our restricted stock activity for the three months ended March 31, 2023 is as follows:

We withheld a total of 240,000 shares as payment for withholding taxes due in connection with the vesting of restricted stock awards during the three months ended March 31, 2023, and the price paid per share of $0.26 reflects the market value per share of the shares withheld for tax purposes. 

Stock-based compensation expense is recognized using the straight-line attribution method over the employees’ requisite service period, or the non-employee's service period based on the term of the contract. We recognize compensation expense for only the portion of stock options or restricted stock expected to vest. Therefore, we apply estimated forfeiture rates that are derived from historical employee attrition. If the actual number of forfeitures differs from those estimated by management, additional adjustments to stock-based compensation expense may be required in future periods.

At September 30, 2022,March 31, 2023, we had unrecognized compensation expense related to stock options of $614,000$543,000 to be recognized over a weighted-average period of 2.3 years.

The following table summarizes the stock-based compensation expense (in thousands):

The Company issued a common stock award of 75,000 shares under the 2022 Plan pursuant to a consulting agreement that resulted in $17,000 of stock compensation expense as seen in the above table. 

We employ the following key weighted-average assumptions in determining the fair value of stock options, using the Black-Scholes option pricing model and the simplified method to estimate the expected term of “plain vanilla” options:

The aggregate intrinsic value of stock options outstanding at September 30, 2022March 31, 2023 was approximately $96,000$69,000 and for options exercisable was also $96,000.$61,000. The intrinsic value of outstanding and exercisable stock options is calculated as the quoted market price of the stock at the balance sheet date less the exercise price of the option. There were no options exercised during the three or ninemonths ended September 30, March 31, 2023 and 2022.There were 797,306 options exercised with an aggregate intrinsic value of $435,000 during the nine months ended September 30, 2021.

On February 15, 2022, Jones issued an aggregate of 20,000,048 Jones Sharesshares of our common stock in connection with the completion of the Plan of Arrangement whereby the outstanding common shares of Pinestar Shares(“Pinestar Shares”) were exchanged for newly issued Jones Sharesshares of our common stock on a one-for-one basis. The Plan of Arrangement had previously been approved by both Pinestar’s shareholders as well as by the Supreme Court of British Columbia after such court held a hearing on the fairness of the terms and conditions of the Plan of Arrangement at which all Pinestar shareholders had the right to appear.

In connection with the Plan of Arrangement, Pinestar completed the Pinestar Subscription Receipt Offeringa subscription receipt offering for aggregate net proceeds of $7,152,000, at a price per subscription receipt equal to $0.50. As part of the closing of the Plan of Arrangement, each such subscription receipt automatically converted into one Pinestar Share and one new common share purchase warrant of Pinestar, which were then immediately exchanged for Jones Sharesshares of our common stock and Jones Special Warrants, respectively, in accordance with a 1:1 exchange ratio.

The issuance of Jones Sharesshares of our common stock to the holders of Pinestar Shares (including Pinestar Shares received upon the conversion of the subscription receipts issued in the Pinestar Subscription Receipt Offering)subscription receipt offering) in the Plan of Arrangement was exempt from the registration requirements under the United States Securities Act of 1933, as amended (the “Securities Act”) pursuant to Section 3(a)(10) of the Securities Act, which exempts from the registration requirements under the Securities Act any securities that are issued in exchange for one or more bona fide outstanding securities where the terms and conditions of such issuance and exchange are approved, after a hearing upon the fairness of such terms and conditions at which all persons to whom it is proposed to issue securities in such exchange shall have the right to appear, by any court expressly authorized by law to grant such approval.

The following table summarizes the Company's outstanding warrants as of March 31, 2023:

(1) Upon conversion of the beforementioned 2021 Debenture, 4,025,035 Jones Special Warrants were issued. In connection with the beforementioned Plan of Arrangement, Pinestar completed an offering for subscription receipts for aggregate gross proceeds of $8,000,000. Pursuant to the Plan of Arrangement, each subscription receipt automatically converted into 16,000,000 Jones Special Warrants. Lastly, Upon conversion of the beforementioned Contingent Convertible Debentures, 6,022,102 Jones Special Warrants were issued.

(2) In connection with the beforementioned Plan of Arrangement, 1,674,808 warrants to purchase Pinestar Shares at a price of $0.06 CAD per share were assumed by the Company and became exercisable into shares of our common stock. An aggregate of 600,000 of such warrants were subsequently transferred to two members of our Board of Directors as consideration for services provided by such directors to the Company during 2022.

We have one operating segment with operations primarily in the United States and Canada. Sales are assigned to geographic locations based on the location of customers. Sales by geographic location are as follows (in thousands):

During the three months ended September 30, 2022March 31, 2023 and 2021,2022, one of our customers (Lassonde) represented an aggregate of approximately 18% and 20% of our revenue, respectively. During the nine months ended September 30, 2022 and 2021, one of our customers (Lassonde) represented an aggregate of approximately 18% and 21% of our revenue, respectively.

Effective November 15, 2021, the Company entered into a one year financing agreement with IPFS Corporation to fund a portion of its insurance premiums in the amount of $903,000. Repayments were made quarterly on January 15, 2022, April 15, 2022, and July 15, 2022, and the entirety of the financing was paid off in full on July 15, 2022. The interest rate was 4.75% and there were no covenants associated with this agreement.

Effective November 15, 2022, the Company entered into a one year financing agreement with IPFS Corporation to fund a portion of its insurance premiums in the amount of $612,000. Repayments are made quarterly on January 15, 2023, April 15, 2023, and by July 15, 2023, the entirety of the financing is expected to be paid off in full. The interest rate is 6.99% and there are no covenants associated with this agreement. As of March 31, 2023 the principal balance was $408,000.

You should read the following discussion and analysis in conjunction with our unaudited condensed consolidated financial statements and related notes included elsewhere in this Report and the 20212022 audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K, which was filed with the Securities and Exchange Commission (“SEC”) on March 14, 2022.29, 2023.

This Report contains forward-looking statements. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “believe,” “expect,” “intend,” “anticipate,” “estimate,” “may,” “will,” “can,” “plan,” “predict,” “could,” “future,” “continue,” variations of such words, and similar expressions. These statements are only predictions. Actual events or results may differ materially. In evaluating these statements, you should specifically consider various factors, including the risks outlined at the beginning of this Report under “Cautionary Notice Regarding Forward-Looking Statements” and in Item 1A of our most recent Annual Report on Form 10-K filed with the SEC, and in our other reports we file with the SEC, including our periodic reports on Form 10-Q and current reports on Form 8-K. These factors may cause our actual results to differ materially from any forward-looking statements. Except as required by law, we undertake no obligation to publicly release any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Overview

We develop, produce, market and distribute premium beverages that we sell and distribute primarily in the United States and Canada through our network of independent distributors and directly to our national and regional retail accounts. We also sell products in select international markets. Our products are sold in grocery stores, convenience and gas stores, on fountain in restaurants, “up and down the street” in independent accounts such as delicatessens, sandwich shops and burger restaurants, as well as through our national accounts with several large retailers. We refer to our network of independent distributors as our direct store delivery (“DSD”) channel, and we refer to our national and regional accounts who receive shipments directly from us as our direct to retail (“DTR”) channel. We do not directly manufacture our products, but instead outsource the manufacturing process to third-party contract manufacturers. We also sell various products online, including soda with customized labels, wearables, candy and other items, and we license our trademarks for use on products sold by other manufacturers.

Our Focus: Sales Growth

Our focus is sales growth through execution of the following key initiatives:

Results of Operations

The following selected financial and operating data are derived from our condensed consolidated financial statements and should be read in conjunction with our condensed consolidated financial statements.

Seasonality and Other Fluctuations

Our sales are seasonal and we experience fluctuations in quarterly results as a result of many factors. We historically have generated a greater percentage of our revenues during the warm weather months of April through September. Sales may fluctuate materially on a quarter to quarter basis or an annual basis when we launch a new product or fill the “pipeline” of a new distribution partner or a large retail partner. Sales results may also fluctuate based on the number of stock keeping units or "SKUs" selected or removed by our distributors and retail partners through the normal course of serving consumers in the dynamic, trend-oriented beverage industry. As a result, management believes that period-to-period comparisons of results of operations are not necessarily meaningful and should not be relied upon as any indication of future performance or results expected for the fiscal year.

Quarter Ended September 30, 2022March 31, 2023 Compared to Quarter Ended September 30, 2021March 31, 2022

Revenue

For the quarter ended September 30, 2022,March 31, 2023, revenue increaseddecreased by approximately $241,000,$653,000, or 5.3%14.4%, to approximately $4.8$3.9 million compared to approximately $4.6$4.5 million for the quarter ended September 30, 2021. This increaseMarch 31, 2022. The decrease in sales revenue in the first quarter of 2023 compared to the first quarter of 2022 was primarily athe result of increasedlower DSD and DTR core bottled soda sales in the United States and Canada. Additionally, we began to generate revenueCanada in the thirdcurrent quarter compared to the same quarter of 2022. Core bottle soda sales in the first quarter of 2023 were lower than the first quarter of 2022 frommostly as a result of a one-time inventory stocking event with one of our line of “Mary Jones” cannabis products launchedlargest customers in 2022. In particular, we incurred s licensing revenue of $114,000 from our Mary Jones products during the quarter ended September 30, 2022. 2022 resulting in higher sales revenues in that quarter.

For the quarter ended September 30, 2022,March 31, 2023, trade spend and promotion allowances, which reduced the amount of revenue for the sales of our product, totaled approximately $397,000, an increase$305,000, a decrease of approximately $20,000,$3,000, or 5.3%1.0%, compared to approximately $377,000$308,000 for the quarter ended September 30, 2021,March 31, 2022, primarily due to the timing of incentive and retailer programs.

Gross Profit

For the quarter ended September 30, 2022,March 31, 2023, gross profit decreased by approximately $172,000,$102,000, or 11.8%8.2%, to approximately $1.3$1.1 million compared to approximately $1.5$1.2 million for the quarter ended September 30, 2021.March 31, 2022 as a result of lower sales revenue in the current quarter. For the quarter ended September 30, 2022,March 31, 2023, gross margin decreasedincreased to 26.9%29.3% from 32%27.3% for the quarter ended September 30, 2021.March 31, 2022. This decreaseincrease was primarily driven by the impacts of inflation, mostly driven by increased materialproactive pricing adjustments and lower freight costs andduring the overall impacts of product mix.current quarter.

Selling and Marketing Expenses

Selling and marketing expenses for the first quarter ended September 30, 2022March 31, 2023 were approximately $1.5$1.0 million, an increasea decrease of approximately $774,000,$111,000, or 105.6%9.7%, from approximately $733,000$1.1 million for the first quarter ended September 30, 2021.March 31, 2022. This decrease was primarily a result of the decrease in marketing start-up costs associated with the launch of our cannabis products in 2022. We continue to invest in marketing our cannabis products, but our costs in in the first quarter of 2023 are less than the same quarter of 2022 mostly due to the start-up costs associated with the launch of such products becoming no longer necessary in 2023. Selling and marketing expenses as a percentage of revenue increased to 32.1%26.7% in the first quarter ended September 30, 2022March 31, 2023 from 16.1%25.3% in the same period in 2021. This increase was primarily a result of non-cash stock consideration paid by the Company in connection with two sponsorship agreements entered into by the Company during the third quarter of 2022. Additionally, the increase in marketing expenses during the current quarter compared to the third quarter of 2021 can also be attributed to marketing expenses associated with the launch of the Company’s cannabis products in 2022 combined with increased social and digital marketing expenses incurred during the quarter in an effort to expand customer engagement. We intend towill continue to balance selling and marketing expenses with our working capital resources. For the three months ended September 30,March 31, 2023 and 2022, and 2021, non-cash expenses included in selling and marketing expenses (stock compensation and depreciation) were approximately $547,000$27,000 and $21,000,$103,000, respectively. This increase in non-cash expenses is primarily attributable to the beforementioned non-cash stock consideration paid by the Company in connection with two sponsorship agreements. 

General and Administrative Expenses

General and administrative expenses for the first quarter ended September 30, 2022March 31, 2023 were approximately $1.5$1.46 million, an increasea decrease of approximately $759,000,$66,000, or 106%4.3%, compared to approximately $716,000$1.52 for the first quarter ended September 30, 2021.March 31, 2022. This decrease was primarily a result of the decrease in general business start-up costs associated with the launch of our cannabis products in 2022. General and administrative expenses as a percentage of revenue increased to 31.4%37.6% in the first quarter ended September 30, 2022March 31, 2023 from 15.7%33.7% in the same periodquarter in 2021. This increase in general and administrative expenses was primarily due to the start-up administrative costs associated with the cannabis product launch.2022. We intend towill continue to carefully manage general and administrative expenses with our working capital resources. For the three months ended September 30,March 31, 2023 and 2022, and 2021, non-cash expenses included in general and administrative expenses (stock compensation and depreciation) were approximately $145,000$247,000 and $27,000,$182,000, respectively. The increase in non-cash expenses in the current quarter compared to the same quarter of 2021 was mostly driven by stock compensation granted to the members of the Board of Directors and members of Management during 2022. 

Interest Income

We earned approximately $1,000 of interest income for both quarters ended September 30, 2022 and 2021.

Interest Expense

We incurred no interest expense for the quarter ended September 30, 2022,March 31, 2023, compared to approximately $76,000$231,000 for the quarter ended September 30, 2021, whichMarch 31, 2022. This decrease was primarily related to the resultconversions of the Contingent Convertible Debentures and Convertible Notes (each as defined in Note 4)some of our outstanding convertible notes that were outstanding and accruing interestoccurred during the three months ended September 30, 2021. Since all of the outstanding Continent Convertible Debentures and Convertible Notes were either converted into shares of our common stock or matured pursuant to their terms prior to the start of the third quarter ofMarch 31, 2022 and there was no other outstanding convertible debt at any time duringthat resulted in all capitalized costs associated with the quarter ended September 30, 2022, the Company did not incur any accrued interest during the current quarter.issuance of these notes being fully expensed upon conversion. The interest expense incurred during the quartersquarter ended September 30, 2021March 31, 2022 was non-cash.

Income Tax Expense

We incurred approximately $8,000$5,000 and $7,000 of income tax expense during each of the quarters ended September 30,March 31, 2023 and 2022, and 2021,respectively, primarily related to the tax provision on income from our Canadian operations. We have not recorded any tax benefit for the loss in our U.S. operations as we have recorded a full valuation allowance on our U.S. net deferred tax assets. We expect to continue to record a full valuation allowance on our U.S. net deferred tax assets until we sustain an appropriate level of taxable income through improved U.S. operations. Our effective tax rate is based on recurring factors, including the forecasted mix of income before taxes in various jurisdictions, estimated permanent differences and the recording of a full valuation allowance on our U.S. net deferred tax assets.

Net loss

Net loss for the first quarter ended September 30, 2022March 31, 2023 was approximately $1.7$1.4 million compared to net incomeloss of approximately $59,000$1.7 million for the first quarter ended September 30, 2021.March 31, 2022. This decrease in net incomeloss was primarily due to the increaseddecreased marketing and administrative costs associated with the launch of our cannabis products in 2022 and the non-cash stock consideration issued pursuantdecrease in interest expense being partially offset by reduced revenues in the first quarter of 2023 compared to the terms of two sponsorship agreements entered into by the Company during the thirdfirst quarter of 2022.

Nine Months Ended September 30, 2022 Compared to Nine Months Ended September 30, 2021

Revenue

For the nine months ended September 30, 2022, revenue increased by approximately $3.5 million, or 29.2%, to approximately $15.3 million compared to approximately $11.9 million for the nine months ended September 30, 2021. This increase was primarily a result of increased DSD and DTR core bottled soda sales in the United States and Canada.

For the nine months ended September 30, 2022, trade spend and promotion allowances, which offset revenue, totaled approximately $1.2 million for each of the nine months ended September 30, 2022 and 2021. Trade spend and promotion allowances fluctuate primarily due to the timing of incentive and retailer programs.

Gross Profit

For the nine months ended September 30, 2022, gross profit increased by approximately $590,000, or 16.3%, to approximately $4.2 million compared to approximately $3.6 million for the nine months ended September 30, 2021 due to higher revenues during the nine months ended September 30, 2022. For the nine months ended September 30, 2022, gross margin decreased to 27.5% from 30.5% for the nine months ended September 30, 2021. This decrease was primarily driven by the impacts of inflation, mostly driven by increased material and freight costs, and the overall impacts of product mix.

Selling and Marketing Expenses

Selling and marketing expenses for the nine months ended September 30, 2022 were approximately $4.9 million, an increase of approximately $2.7 million, or 127.2%, from approximately $2.1 million for the nine months ended September 30, 2021. Selling and marketing expenses as a percentage of revenue increased to 24.5% for the nine months ended September 30, 2022 from 17.7% in the same period in 2021. This increase was primarily a result of non-cash stock consideration paid by the Company in connection with two sponsorship agreements entered into by the Company during the third quarter of 2022. Additionally, the increase in marketing expenses during the current period compared to the first nine months of 2021 can also be attributed to marketing expenses associated with the launch of the Company’s cannabis products in 2022 combined with increased social and digital marketing expenses incurred during the 2022 in an effort to expand customer engagement. We intend to continue to balance selling and marketing expenses with our working capital resources. For the nine months ended September 30, 2022 and 2021, non-cash expenses included in selling and marketing expenses (stock compensation and depreciation) were approximately $681,000 and $80,000, respectively. This increase in non-cash expenses is primarily attributable to the beforementioned non-cash stock consideration paid by the Company in connection with two sponsorship agreements. 

General and Administrative Expenses

General and administrative expenses for the nine months ended September 30, 2022 were approximately $4.9 million, an increase of approximately $2.7 million, or 127.2%, compared to approximately $2.1 million for the nine months ended September 30, 2021. General and administrative expenses as a percentage of revenue increased to 32.0% in the nine months ended September 30, 2022 from 18.1% in the same period in 2021. This increase in general and administrative expenses was primarily due to the start-up administrative costs associated with the cannabis product launch. We intend to continue to carefully manage general and administrative expenses with our working capital resources. For the nine months ended September 30, 2022 and 2021, non-cash expenses included in general and administrative expenses (stock compensation and depreciation) were approximately $426,000 and $97,000, respectively. The increase in non-cash expenses during 2022 compared to 2021 was mostly driven by stock compensation granted to the members of the Board of Directors and members of Management during 2022. 

Interest Income

We earned approximately $5,000 of interest income for the nine months ended September 30, 2022, compared to $3,000 for the nine months ended September 30, 2021.

Interest Expense

We incurred approximately $377,000 of interest expense for the nine months ended September 30, 2022, compared to approximately $160,000 for the nine months ended September 30, 2021 which was the result of the Contingent Convertible Debentures and Convertible Notes (each as defined in Note 4) that were outstanding and accruing interest during the full nine months ended September 30, 2021. Since all of the outstanding Continent Convertible Debentures and Convertible Notes were either converted into shares of our common stock or matured pursuant to their terms during the first half of 2022, the Company did not incur accrued interest during the entire nine month period ended September 30, 2022. The interest expense incurred during the quarters ended September 30, 2021 was non-cash.

Income Tax Expense

We incurred approximately $24,000 of income tax expense in each of the nine months ended September 30, 2022 and 2021, respectively, primarily related to the tax provision on income from our Canadian operations. We have not recorded any tax benefit for the loss in our U.S. operations as we have recorded a full valuation allowance on our U.S. net deferred tax assets. We expect to continue to record a full valuation allowance on our U.S. net deferred tax assets until we sustain an appropriate level of taxable income through improved U.S. operations. Our effective tax rate is based on recurring factors, including the forecasted mix of income before taxes in various jurisdictions, estimated permanent differences and the recording of a full valuation allowance on our U.S. net deferred tax assets.

Other income (expense)

We incurred approximately $11,000 of other income during the nine months ended September 30, 2022 and $338,000 of other income during the nine months ended September 30, 2021. This decrease in other income was primarily due to our recognition of gain on debt forgiveness related to the full forgiveness of our $334,500 loan under the Paycheck Protection Plan ( the “PPP Loan”) during the nine months ended September 30, 2021.

Net loss

Net loss for the nine months ended September 30, 2022 was approximately $4.8 million compared to net loss of approximately $469,000 for the nine months ended September 30, 2021. This increase in net loss was primarily due to the increase marketing and administrative costs associated with our cannabis product launch and the increase in interest expense that occurred during the first nine months of 2022. Additionally, during the nine months ended September 30, 2021 we experienced a large increase in other income due to our recognition of gain on debt forgiveness related to the full forgiveness of our PPP Loan in the principal amount of $334,500.

Liquidity and Capital Resources

As of September 30, 2022March 31, 2023 and December 31 2021,2022, we had cash and cash-equivalents of approximately $8.2$6.4 million and $4.7$8.0 million, respectively, and working capital of approximately $12.9$10.5 million and $6.0$11.6 million, respectively. Net cash used in operations during the ninethree months ended September 30,March 31, 2023 and 2022 and 2021 totaled approximately $5.9$1.3 million and $702,000,$2.0 million, respectively. Net cash used in operations increaseddecreased in the first quarter of 2023 compared to the first quarter of 2022 primarily due to the increasedecrease in cash used as start-up expenses related to expanding our business to the productionlaunch of the Company’s cannabis-containing beverages and related products as of September 30, 2022.during the three months ended March 31, 2023.

During the nine months ended September 30, 2022, we issued $3,000,000 in Contingent Convertible Debentures (See note 4), that fully converted into 6,022,192 shares of common stock on May 16, 2022.

Additionally, upon the consummation of a statutory plan of arrangement under the Business Corporations Act (British Columbia) (the “Plan of Arrangement”) with Pinestar Gold Inc. (“Pinestar”) the Company received $7.1 million in net proceeds from a subscription receipt offering completed by Pinestar (the “Pinestar Subscription Receipt Offering”) prior to the Plan of Arrangement. The Plan of Arrangement resulted in issuance of an aggregate of 20,000,048 shares of the Company’s common stock which were issued in exchange for all of the outstanding common shares of Pinestar (the “Pinestar Shares”), including the Pinestar Shares issued in connection with the Pinestar Subscription Receipt Offering, on a one-for-one basis.

During the three and nine months ended September 30, 2022, we received $0We did not receive any cash from the cash exercise of stock options. During the three and nine months ended September 30, 2021, we received $228,000 and $295,000, respectively, from the cash exerciseoptions as of stock options.March 31, 2023 or 2022. From time to time, we may receive additional cash through the exercise of stock options or stock warrants. However, we cannot predict the timing or amount of cash proceeds we may receive from the exercise, if at all, of any of the outstanding stock options or warrants.

We intend to continually monitor and adjust our operating plan as necessary to respond to developments in our business, our markets and the broader economy. In addition, the continuation of the COVID-19 pandemic and uncertain supply chain conditions, may reduce demand for certain products, and may negatively impact our business.

As of the date of this Report, as a result of our cash on hand, we believe that our current cash and cash equivalents will be sufficient to meet the Company’s funding requirements for one year after these condensed consolidated financial statements are issued.

Critical Accounting Policies

See the information concerning our critical accounting policies included under “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operation – Critical Accounting Policies” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021,2022, filed with the SEC on March 14, 2022.29, 2023. There have been no material changes in our critical accounting policies during the ninethree months ended September 30, 2022.March 31, 2023.

Not applicable.

We maintain disclosure controls and procedures (as such terms are defined under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that are designed to ensure that the information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Management, under the supervision and with the participation of our Chief Executive Officer and PrincipalChief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Exchange Act Rule 13a-15(b) as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that these disclosure controls and procedures were effective as of September 30, 2022.March 31, 2023.

In response to the material weakness described in our most recently filed Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on March 29, 2023, with the oversight of the Audit Committee of our Board of Directors, management is currently evaluating our policies and procedures related to the accounting for short term financings and is working to implement adequate internal controls to ensure that (i) the liability associated with short-term financings are identified and recorded properly, and (ii) the associated asset with said financings are identified and recorded.

The remediation efforts are intended both to address the identified material weakness and to enhance our overall financial control environment. Management is committed to continuous improvement of the Company’s internal control over financial reporting and will continue to diligently review the Company’s internal control over financial reporting.

There were no other changes in our internal controls over financial reporting during the three months ended September 30, 2022March 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

PART II – OTHER INFORMATION

We are or may be involved from time to time in various claims and legal actions arising in the ordinary course of business, including proceedings involving employee claims, contract disputes, product liability and other general liability claims, as well as trademark, copyright, and related claims and legal actions. In the opinion of our management, the ultimate disposition of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity.